Satishkumar Mohanavelu

2.5k total citations · 3 hit papers
26 papers, 1.8k citations indexed

About

Satishkumar Mohanavelu is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Satishkumar Mohanavelu has authored 26 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 4 papers in Internal Medicine. Recurrent topics in Satishkumar Mohanavelu's work include Acute Myocardial Infarction Research (15 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Heart Rate Variability and Autonomic Control (5 papers). Satishkumar Mohanavelu is often cited by papers focused on Acute Myocardial Infarction Research (15 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Heart Rate Variability and Autonomic Control (5 papers). Satishkumar Mohanavelu collaborates with scholars based in United States, Brazil and Poland. Satishkumar Mohanavelu's co-authors include Elliott M. Antman, Christopher P. Cannon, Carolyn H. McCabe, Sabina A. Murphy, Sean M. Donahoe, Garrick C. Stewart, C. Michael Gibson, Eugene Braunwald, Robert P. Giugliano and Paul Burton and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Satishkumar Mohanavelu

25 papers receiving 1.8k citations

Hit Papers

Diabetes and Mortality Following Acute Coronary Syndromes 2007 2026 2013 2019 2007 2009 2012 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Diabetes and Mortality Following Acute Coronary Syndromes
    2007 511 citations Sean M. Donahoe, Garrick C. Stewart et al. JAMA profile →
  2. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
    2009 488 citations Eugene Braunwald, Satishkumar Mohanavelu et al. The Lancet profile →
  3. Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study
    2012 354 citations Robert P. Giugliano, Nihar R. Desai et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satishkumar Mohanavelu United States 16 1.2k 743 344 273 241 26 1.8k
Marek Koziński Poland 27 1.5k 1.2× 870 1.2× 243 0.7× 266 1.0× 261 1.1× 132 2.3k
Egbert T. Bal Netherlands 18 1.4k 1.2× 1.5k 2.0× 254 0.7× 249 0.9× 482 2.0× 36 2.3k
Ernesto Paolasso Argentina 17 1.5k 1.2× 469 0.6× 329 1.0× 300 1.1× 274 1.1× 19 2.0k
Róbert Gábor Kiss Hungary 17 1.2k 1.0× 443 0.6× 357 1.0× 267 1.0× 85 0.4× 93 1.7k
Annunziata Nusca Italy 18 1.1k 0.9× 954 1.3× 128 0.4× 295 1.1× 339 1.4× 102 2.0k
Ralph Vicari United States 6 1.5k 1.2× 1.1k 1.4× 149 0.4× 227 0.8× 727 3.0× 16 2.0k
M. L. Simoons Netherlands 17 1.1k 0.9× 430 0.6× 147 0.4× 183 0.7× 292 1.2× 44 1.4k
Robin Mukherjee United States 11 1.2k 1.0× 1.0k 1.4× 69 0.2× 879 3.2× 145 0.6× 16 2.1k
Yuyin Liu United States 18 576 0.5× 378 0.5× 131 0.4× 202 0.7× 76 0.3× 67 1.2k
Russell J. Ivanhoe United States 12 2.5k 2.0× 1.4k 1.8× 148 0.4× 96 0.4× 623 2.6× 19 3.3k

Countries citing papers authored by Satishkumar Mohanavelu

Since Specialization
Citations

This map shows the geographic impact of Satishkumar Mohanavelu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satishkumar Mohanavelu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satishkumar Mohanavelu more than expected).

Fields of papers citing papers by Satishkumar Mohanavelu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satishkumar Mohanavelu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satishkumar Mohanavelu. The network helps show where Satishkumar Mohanavelu may publish in the future.

Co-authorship network of co-authors of Satishkumar Mohanavelu

This figure shows the co-authorship network connecting the top 25 collaborators of Satishkumar Mohanavelu. A scholar is included among the top collaborators of Satishkumar Mohanavelu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satishkumar Mohanavelu. Satishkumar Mohanavelu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gibson, C. Michael, Anjan Chakrabarti, Jessica L. Mega, et al.. (2013). Reduction of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Rivaroxaban in ATLAS-ACS 2 TIMI 51. Journal of the American College of Cardiology. 62(4). 286–290. 73 indexed citations
2.
Kohli, Payal, et al.. (2012). プロタンパク質転換酵素サブチリシンKexin9型(PCSK9)に対する完全ヒトモノクローナル抗体AMG145は,ハイリスク患者におけるNCEP低密度リポタンパク質-コレステロール目標値の達成を促進する. Circulation. 126(23). 2791. 1 indexed citations
3.
Giugliano, Robert P., Nihar R. Desai, Payal Kohli, et al.. (2012). Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study. The Lancet. 380(9858). 2007–2017. 354 indexed citations breakdown →
4.
Pride, Yuri B., Satishkumar Mohanavelu, Cafer Zorkun, et al.. (2012). Association Between Angiographic Complications and Clinical Outcomes Among Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions. 5(9). 927–935. 17 indexed citations
5.
Mogabgab, Owen, Robert P. Giugliano, Marc S. Sabatine, et al.. (2012). Circadian Variation in Patient Characteristics and Outcomes in ST-Segment Elevation Myocardial Infarction. Chronobiology International. 29(10). 1390–1396. 15 indexed citations
6.
Pride, Yuri B., Patricia Tung, Satishkumar Mohanavelu, et al.. (2010). Angiographic and Clinical Outcomes Among Patients With Acute Coronary Syndromes Presenting With Isolated Anterior ST-Segment Depression. JACC: Cardiovascular Interventions. 3(8). 806–811. 70 indexed citations
7.
Syed, Zeeshan, Benjamin M. Scirica, Satishkumar Mohanavelu, et al.. (2010). Abstract 15908: Association of Heart Rate Turbulence, Deceleration Capacity and Morphologic Variability with Sudden Cardiac Death Following Non-ST-Elevation Acute Coronary Syndrome: Results from the MERLIN-TIMI 36 Trial. Circulation. 122. 88–91.
8.
Pride, Yuri B., Satishkumar Mohanavelu, Caitlin Harrigan, et al.. (2010). Relation Between Infarct Size in ST-Segment Elevation Myocardial Infarction Treated Successfully by Percutaneous Coronary Intervention and Left Ventricular Ejection Fraction Three Months After the Infarct. The American Journal of Cardiology. 106(5). 635–640. 27 indexed citations
9.
Giugliano, Robert P., Roberto R. Giraldez, David A. Morrow, et al.. (2010). Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial. European Heart Journal. 31(17). 2103–2110. 28 indexed citations
10.
Wiviott, Stephen D., Satishkumar Mohanavelu, Joel S. Raichlen, et al.. (2009). Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein Cholesterol Levels With Rosuvastatin 40 mg Daily (from the ASTEROID Study). The American Journal of Cardiology. 104(1). 29–35. 18 indexed citations
11.
Frisch, Daniel R., Evaldas Giedrimas, Satishkumar Mohanavelu, et al.. (2009). Predicting Irreversible Left Ventricular Dysfunction After Acute Myocardial Infarction. The American Journal of Cardiology. 103(9). 1206–1209. 8 indexed citations
12.
Scirica, Benjamin M., David A. Morrow, Andrzej Budaj, et al.. (2009). Ischemia Detected on Continuous Electrocardiography After Acute Coronary Syndrome. Journal of the American College of Cardiology. 53(16). 1411–1421. 39 indexed citations
13.
Braunwald, Eugene, Satishkumar Mohanavelu, Paul Burton, et al.. (2009). Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial. The Lancet. 374(9683). 29–38. 488 indexed citations breakdown →
14.
Mielniczuk, Lisa, Marc A. Pfeffer, Eldrin F. Lewis, et al.. (2009). Acute Decline in Renal Function, Inflammation, and Cardiovascular Risk after an Acute Coronary Syndrome. Clinical Journal of the American Society of Nephrology. 4(11). 1811–1817. 27 indexed citations
15.
Mega, Jessica L., David A. Morrow, James A. de Lemos, et al.. (2008). Thrombus Precursor Protein and Clinical Outcomes in Patients With Acute Coronary Syndromes. Journal of the American College of Cardiology. 51(25). 2422–2429. 22 indexed citations
16.
Giraldez, Roberto R., Robert P. Giugliano, Satishkumar Mohanavelu, et al.. (2008). Baseline Low-Density Lipoprotein Cholesterol Is an Important Predictor of the Benefit of Intensive Lipid-Lowering Therapy. Journal of the American College of Cardiology. 52(11). 914–920. 54 indexed citations
17.
Syed, Zeeshan, Benjamin M. Scirica, Satishkumar Mohanavelu, et al.. (2008). Relation of Death Within 90 Days of Non-ST-Elevation Acute Coronary Syndromes to Variability in Electrocardiographic Morphology. The American Journal of Cardiology. 103(3). 307–311. 20 indexed citations
18.
Giraldez, Roberto R., José Carlos Nicolau, Ramón Corbalán, et al.. (2007). Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis. European Heart Journal. 28(13). 1566–1573. 31 indexed citations
19.
Donahoe, Sean M., Garrick C. Stewart, Carolyn H. McCabe, et al.. (2007). Diabetes and Mortality Following Acute Coronary Syndromes. JAMA. 298(7). 765–765. 511 indexed citations breakdown →
20.
Ruff, Christian T., Stephen D. Wiviott, David A. Morrow, et al.. (2007). TIMI Risk Index and the Benefit of Enoxaparin in Patients with ST-Elevation Myocardial Infarction. The American Journal of Medicine. 120(11). 993–998. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marek Koziński Breakdown of academic impact, for papers by Egbert T. Bal Breakdown of academic impact, for papers by Ernesto Paolasso Breakdown of academic impact, for papers by Róbert Gábor Kiss Breakdown of academic impact, for papers by Annunziata Nusca Breakdown of academic impact, for papers by Ralph Vicari Breakdown of academic impact, for papers by M. L. Simoons Breakdown of academic impact, for papers by Robin Mukherjee Breakdown of academic impact, for papers by Yuyin Liu Breakdown of academic impact, for papers by Russell J. Ivanhoe
Rankless by CCL
2026